QR Kod

Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results

This study presents the preliminary results of a new otosurgical method in patients after canal wall down (CWD) surgery; it involves the implantation of the Bonebridge BCI 602 implant after obliteration of the mastoid cavity with S53P4 bioactive glass. The study involved eight adult patients who had...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Bartłomiej Król, Katarzyna Beata Cywka, Magdalena Beata Skarżyńska, Piotr Henryk Skarżyński
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI AG 2021-04-01
Seri Bilgileri:Life
Konular:
S53P4 bioactive glass
cholesteatoma
mastoid obliteration
otosurgery
Bonebridge BCI 602
bone conduction implant
Online Erişim:https://www.mdpi.com/2075-1729/11/5/374
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller